Global Biotechnology Industry Profile & Value Chain Analysis

Global Biotechnology industry profile provides top-line qualitative and quantitative summary information including: market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

The value chain analysis reveals the business activities which comprise the global biotechnology industry value chain. All key stages are highlighted, along with examples of companies active, and assessments of the burning issues for every stage of the value chain. Key value chain stages analyzed include raw materials, chemicals, biotechnology producers, and B2B end users.

Synopsis

Essential resource for top-line data and analysis covering the global biotechnology industry. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key Highlights

– The biotechnology industry consists of the development, manufacturing, and marketing of products based on advanced biotechnology research.

– The global biotechnology industry had total revenues of $353.9bn in 2016, representing a compound annual growth rate (CAGR) of 8.8% between 2012 and 2016.

– The medical/healthcare segment was the industry's most lucrative in 2016, with total revenues of $202.3bn, equivalent to 57.2% of the industry's overall value.

– Globally, the biotechnology industry is driven by the US and Asia-Pacific which make up 46.5% and 24.9% respectively.

– Biotechnology’s wide applications mean it has various B2B End-users. The main verticals are healthcare, agriculture, consumer products and industrial manufacturing

Scope

– Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology industry

– Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global biotechnology industry

– Leading company profiles reveal details of key biotechnology industry players’ global operations and financial performance

– Add weight to presentations and pitches by understanding the future growth prospects of the global biotechnology industry with five year forecasts

– Quickly and easily identify the key stages and sub-stages of the global biotechnology industry value chain

– See examples of companies active at each stage of the global biotechnology industry value chain

– Examine trends and burning issues impacting the global biotechnology industry value chain

Reasons to buy

- What was the size of the global biotechnology industry by value in 2016?

- What will be the size of the global biotechnology industry in 2021?

- What factors are affecting the strength of competition in the global biotechnology industry?

- How has the market performed over the last five years?

- What are the main segments that make up the global biotechnology industry?

- What are the key stages of the global biotechnology industry value chain?

Table of Contents

Table of Contents

Executive Summary 2

Value chain analysis 2

Market value 2

Market value forecast 2

Category segmentation 2

Geography segmentation 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Value Chain Analysis 8

Biotechnology industry complete value chain overview 8

Raw Materials 10

Suppliers 12

Biotechnology Producers 14

B2B End-users 16

Market Data 18

Market value 18

Market Segmentation 19

Category segmentation 19

Geography segmentation 20

Market Outlook 21

Market value forecast 21

Five Forces Analysis 22

Summary 22

Buyer power 23

Supplier power 24

New entrants 25

Threat of substitutes 27

Degree of rivalry 28

Leading Companies 29

Amgen, Inc. 29

Covance Inc. 32

F. Hoffmann-La Roche Ltd 33

Merck & Co., Inc. 36

Methodology 39

Industry associations 40

Related MarketLine research 40

Appendix 41

About MarketLine 41

List of Tables

List of Tables

Table 1: Global biotechnology industry value: $ billion, 2012-16 18

Table 2: Global biotechnology industry category segmentation: $ billion, 2016 19

Table 3: Global biotechnology industry geography segmentation: $ billion, 2016 20

Table 4: Global biotechnology industry value forecast: $ billion, 2016-21 21

Table 5: Amgen, Inc.: key facts 29

Table 6: Amgen, Inc.: key financials ($) 30

Table 7: Amgen, Inc.: key financial ratios 30

Table 8: Covance Inc.: key facts 32

Table 9: F. Hoffmann-La Roche Ltd: key facts 33

Table 10: F. Hoffmann-La Roche Ltd: key financials ($) 34

Table 11: F. Hoffmann-La Roche Ltd: key financials (CHF) 34

Table 12: F. Hoffmann-La Roche Ltd: key financial ratios 34

Table 13: Merck & Co., Inc.: key facts 36

Table 14: Merck & Co., Inc.: key financials ($) 37

Table 15: Merck & Co., Inc.: key financial ratios 37

List of Figures

List of Figures

Figure 1: Biotechnology industry complete value chain overview 8

Figure 2: Biotechnology industry complete value chain with active companies 9

Figure 3: Raw Materials – Overview 10

Figure 4: Suppliers – Overview 12

Figure 5: Biotechnology Producers – Overview 14

Figure 6: B2B End-users – Overview 16

Figure 7: Global biotechnology industry value: $ billion, 2012-16 18

Figure 8: Global biotechnology industry category segmentation: % share, by value, 2016 19

Figure 9: Global biotechnology industry geography segmentation: % share, by value, 2016 20

Figure 10: Global biotechnology industry value forecast: $ billion, 2016-21 21

Figure 11: Forces driving competition in the global biotechnology industry, 2016 22

Figure 12: Drivers of buyer power in the global biotechnology industry, 2016 23

Figure 13: Drivers of supplier power in the global biotechnology industry, 2016 24

Figure 14: Factors influencing the likelihood of new entrants in the global biotechnology industry, 2016 25

Figure 15: Factors influencing the threat of substitutes in the global biotechnology industry, 2016 27

Figure 16: Drivers of degree of rivalry in the global biotechnology industry, 2016 28

Figure 17: Amgen, Inc.: revenues & profitability 31

Figure 18: Amgen, Inc.: assets & liabilities 31

Figure 19: F. Hoffmann-La Roche Ltd: revenues & profitability 35

Figure 20: F. Hoffmann-La Roche Ltd: assets & liabilities 35

Figure 21: Merck & Co., Inc.: revenues & profitability 37

Figure 22: Merck & Co., Inc.: assets & liabilities 38

    Pricing

Quick Buy
Add to basket Enquire before buying

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports